Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Molecular biologist warns of vCJD (variant Creutzfeldt Jakob disease) incidence:

This article was originally published in Clinica

Executive Summary

A senior German molecular biologist has warned that Germany could be faced with up to 12 cases of new variant Creuzfeldt Jakob Disease (vCJD) within the next two years. Professor Konrad Beyreuther from the University of Heidelberg bases his estimate on data gathered from vCJD incidence in the UK, but further advises that the disease could manifest itself in Germany in the form of another variant. An extrapolation of UK data shows that Germany could have up to 1,200 BSE-infected cattle.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT070171

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel